SOLY - Cellectar Biosciences only healthcare gainer; INSYS Therapeutics leads the losers May, 13 2019 11:02 AM Soliton Inc. Gainers: Cellectar Biosciences (NASDAQ:CLRB) +7%.More news on: Cellectar Biosciences, Inc., INSYS Therapeutics, Inc., Soliton, Inc., Healthcare stocks news, Stocks on the move, Read more ...